durvalumab,sorafenib,tremelimumab
astrazeneca,pfizer
['himalaya', 'durva']
himalaya immune mediated adverse events by dr. lau. doubled (36 vs 18%) in durva/tremi group vs durva. os 23.2 vs 14.1 months for those who experienced irae vs those who did not. #asco2023 
Medical oncologist: GI cancers & cancer of unknown primary + high quality & value-based cancer care delivery. @UTexasValue MSHCT student. Tweets mine.